Robert T. Davis, Jr
2018
Compensation breakdown
| Non-Equity Incentive Plan | $272,000 |
|---|---|
| Option Awards | $187,504 |
| Salary | $458,350 |
| Stock Awards | $437,582 |
| Other | $13,980 |
| Total | $1,369,416 |
Davis received $458.4K in salary, accounting for 33% of the total pay in 2018.
Davis also received $272K in non-equity incentive plan, $187.5K in option awards, $437.6K in stock awards and $14K in other compensation.
Rankings
In 2018, Robert T. Davis, Jr's compensation ranked 7,610th out of 14,244 executives tracked by ExecPay. In other words, Davis earned more than 46.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,610 out of 14,244 | 47th |
Division Manufacturing | 2,955 out of 5,765 | 49th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 362 out of 849 | 57th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 203 out of 547 | 63rd |
Industry Surgical and Medical Instruments and Apparatus | 124 out of 348 | 64th |
Pay ratio
| Robert T. Davis, Jr's Pay | $1,369,416 |
|---|---|
| Median Employee's Pay | $73,170 |
| Pay Ratio | 19to 1 |
In 2018, the annual total compensation of Robert T. Davis, Jr was $1,369,416.
The annual total compensation of the median employee at Integra LifeSciences Holdings was $73,170.
The ratio of Robert T. Davis, Jr's pay to the pay of median employee was therefore 19 to one.
Davis' colleagues
We found five more compensation records of executives who worked with Robert T. Davis, Jr at Integra LifeSciences Holdings in 2018.
2018
Peter Arduini
Integra LifeSciences Holdings
Chief Executive Officer
2018
Richard Gorelick
Integra LifeSciences Holdings
General Counsel
2018
Glenn Coleman
Integra LifeSciences Holdings
Chief Financial Officer
2018
Daniel Reuvers
Integra LifeSciences Holdings
Corporate Vice President, President, Codman Surgical Solutions
2018
Eric Schwartz
Integra LifeSciences Holdings
General Counsel
News
April 8, 2022
April 9, 2021
April 8, 2020
April 16, 2019